Pancreatic Cancer Health Disparity: Pharmacologic Anthropology
Abstract
:Simple Summary
Abstract
1. Introduction
2. The Interplay between Pharmacology and Anthropology
3. Pancreatic Cancer Health Disparities
3.1. Socioeconomic Factors
3.2. Cultural and Behavioral Factors
3.3. Access to Healthcare and Treatment Disparities
3.4. Genetic and Biological Factors
3.5. Pancreatic Cancer Screening
4. Pharmacologic Anthropology and Pancreatic Cancer
4.1. Understanding Local Knowledge and Practices
4.2. Assessing Cultural Beliefs and Perceptions
4.3. Community Engagement and Health Education
4.4. Addressing Structural and Systemic Barriers
4.5. Enhancing Patient-Provider Communication
5. Case Studies and Best Practices
5.1. Successful Interventions in Addressing Health Disparities
5.2. Community-Based Participatory Research (CBPR)
- Engaging community members from the outset: Involving community members in this research design, implementation, and dissemination phases ensures that research is responsive to community needs and priorities.
- Building trusting relationships: Establishing trust between researchers and community partners is crucial for successful CBPR. Transparent communication, mutual respect, and recognition of the expertise and contributions of all stakeholders help foster trust and collaboration.
- Incorporating cultural competence: Recognizing and addressing cultural factors that influence health beliefs, practices, and access to care is essential. Cultural competence training for researchers and incorporating cultural perspectives into research protocols ensure that interventions are culturally appropriate.
- Sharing power and resources: CBPR requires equitable power sharing and resource distribution among community partners and researchers. Meaningful involvement of community members in decision-making processes, capacity building, and resource allocation fosters a sense of ownership and sustainability.
- Capacity building: CBPR should include capacity-building efforts to enhance this research skills and knowledge of community members. This empowers community partners to actively contribute to the research process, strengthen their own advocacy efforts, and sustain interventions beyond this research project.
5.3. Culturally Sensitive Interventions
- Engage community members and stakeholders from the target population in the intervention planning, design, and implementation process.
- Conduct a thorough assessment of the cultural beliefs, values, practices, and health disparities prevalent within the community.
- Collaborate with community leaders, cultural organizations, and faith-based institutions to leverage existing resources and networks.
- Train healthcare providers and researchers in cultural competence to enhance their understanding of diverse populations and improve patient-provider communication.
- Provide language-appropriate and culturally relevant educational materials, ensuring they are easily understandable and accessible to the target population.
- Incorporate cultural traditions, rituals, and preferences into interventions to enhance engagement and acceptance.
- Evaluate and adapt interventions based on community feedback and outcomes to ensure ongoing cultural relevance and effectiveness.
5.4. Patient Advocacy and Empowerment
- Facilitating open and honest communication between patients and healthcare providers ensures that patients are active participants in their care.
- Encouraging patients to ask questions, seek second opinions, and actively engage in treatment decision-making.
- Providing clear and accessible information about treatment options, clinical trials, and supportive care services.
- Collaborating with patient advocacy organizations to connect patients with resources, support groups, and educational materials.
- Promoting patient education and health literacy to enhance patients’ understanding of their diagnosis, treatment, and self-care.
- Advocating for policies that improve access to affordable healthcare, clinical trials, and supportive services for PCa patients.
- Recognizing and respecting patients’ cultural, religious, and personal values when developing care plans and support services.
6. Future Directions and Challenges
6.1. Multi-Disciplinary Collaborations
6.2. Precision Medicine and Personalized Care
6.3. Policy Changes and Health Equity
6.4. Technological Innovations and Access
7. Conclusions
- Comprehensive Genetic and Biological Research: Invest in robust research initiatives that delve into the genetic and biological underpinnings of pancreatic cancer, aiming to identify risk factors, biomarkers, and therapeutic targets that can lead to more equitable treatment outcomes.
- Equitable Access and Enhanced Communication: Advocate for policies and interventions that ensure equitable access to healthcare and treatment, while also emphasizing the importance of enhanced patient-provider communications, cultural competence, and shared decision-making in reducing disparities.
Author Contributions
Funding
Acknowledgments
Conflicts of Interest
References
- Afghani, E.; Klein, A.P. Pancreatic Adenocarcinoma: Trends in Epidemiology, Risk Factors, and Outcomes. Hematol. Oncol. Clin. N. Am. 2022, 36, 879–895. [Google Scholar] [CrossRef]
- Tavakkoli, A.; Singal, A.G.; Waljee, A.K.; Elmunzer, B.J.; Pruitt, S.L.; McKey, T.; Rubenstein, J.H.; Scheiman, J.M.; Murphy, C.C. Racial Disparities and Trends in Pancreatic Cancer Incidence and Mortality in the United States. Clin. Gastroenterol. Hepatol. 2020, 18, 171–178.e10. [Google Scholar] [CrossRef] [PubMed]
- Chu, Q.D.; Hsieh, M.C.; Gibbs, J.F.; Wu, X.C. Social determinants of health associated with poor outcome for rural patients following resected pancreatic cancer. J. Gastrointest. Oncol. 2021, 12, 2567–2578. [Google Scholar] [CrossRef] [PubMed]
- DePalo, D.K.; Lee, R.M.; Lopez-Aguiar, A.G.; Gamboa, A.C.; Rocha, F.; Poultsides, G.; Dillhoff, M.; Fields, R.C.; Idrees, K.; Nathan, H.; et al. Interaction of race and pathology for neuroendocrine tumors: Epidemiology, natural history, or racial disparity? J. Surg. Oncol. 2019, 120, 919–925. [Google Scholar] [CrossRef]
- Gad, M.M.; Saad, A.M.; Al-Husseini, M.J.; Abdel-Gawad, Y.M.; Alsalhani, O.M.; Alhaddad, R.; Mohamad, B.; Saleh, M.A.; Simons-Linares, C.R. Temporal trends of pancreatic ductal adenocarcinoma in young adults in the United States: A Population-Based Study. Clin. Res. Hepatol. Gastroenterol. 2020, 44, 204–210. [Google Scholar] [CrossRef] [PubMed]
- Scarton, L.; Yoon, S.; Oh, S.; Agyare, E.; Trevino, J.; Han, B.; Lee, E.; Setiawan, V.W.; Permuth, J.B.; Schmittgen, T.D.; et al. Pancreatic Cancer Related Health Disparities: A Commentary. Cancers 2018, 10, 235. [Google Scholar] [CrossRef]
- Ahuja, A.; Yi, Y.S.; Kim, M.Y.; Cho, J.Y. Ethnopharmacological properties of Artemisia asiatica: A comprehensive review. J. Ethnopharmacol. 2018, 220, 117–128. [Google Scholar] [CrossRef]
- Liu, X.; Li, Z.; Wang, Y. Advances in Targeted Therapy and Immunotherapy for Pancreatic Cancer. Adv. Biol. 2021, 5, e1900236. [Google Scholar] [CrossRef]
- Sun, J.; Russell, C.C.; Scarlett, C.J.; McCluskey, A. Small molecule inhibitors in pancreatic cancer. RSC Med. Chem. 2020, 11, 164–183. [Google Scholar] [CrossRef]
- Martin, A.N.; Snyder, R.A. Racial disparities in pancreatic cancer clinical trials: Defining the problem and identifying solutions. Adv. Cancer Res. 2023, 159, 185–201. [Google Scholar] [CrossRef]
- Katona, B.W.; Klute, K.; Brand, R.E.; Everett, J.N.; Farrell, J.J.; Hawthorne, K.; Kaul, V.; Kupfer, S.S.; Paiella, S.; Simeone, D.M.; et al. Racial, Ethnic, and Sex-based Disparities among High-risk Individuals Undergoing Pancreatic Cancer Surveillance. Cancer Prev. Res. 2023, 16, 343–352. [Google Scholar] [CrossRef]
- Brooks, G.A.; Tomaino, M.R.; Ramkumar, N.; Wang, Q.; Kapadia, N.S.; O’Malley, A.J.; Wong, S.L.; Loehrer, A.P.; Tosteson, A.N.A. Association of rurality, socioeconomic status, and race with pancreatic cancer surgical treatment and survival. J. Natl. Cancer Inst. 2023, 115, 1171–1178. [Google Scholar] [CrossRef]
- Halder, R.; Veeravelli, S.; Cheng, C.; Estrada-Mendizabal, R.J.; Recio-Boiles, A. Health Disparities in Presentation, Treatment, Genomic Testing, and Outcomes of Pancreatic Cancer in Hispanic and Non-Hispanic Patients. J. Racial Ethn. Health Disparities 2023, 1–9. [Google Scholar] [CrossRef] [PubMed]
- Behar-Horenstein, L.; Warren, R.C.; Setiawan, V.W.; Perkins, C.; Schmittgen, T.D. Enhancing African American Participation in Biospecimens: A Case in Point for Pancreatic Cancer. Cancer Health Disparities 2020, 29, 236. [Google Scholar] [CrossRef]
- Xu, C.; Wang, Y.; Yang, H.; Hou, J.; Sun, L.; Zhang, X.; Cao, X.; Hou, Y.; Wang, L.; Cai, Q.; et al. Association Between Cancer Incidence and Mortality in Web-Based Data in China: Infodemiology Study. J. Med. Internet Res. 2019, 21, e10677. [Google Scholar] [CrossRef] [PubMed]
- Coffin, T.B.; Kenner, B.J. Challenges in Recruitment and Retention: Leveraging Health-Related Antecedents and Information Carrier Factors to Improve Patient Participation in Pancreatic Cancer Research-A Review Article. Pancreas 2022, 51, 1074–1082. [Google Scholar] [CrossRef] [PubMed]
- Visser, B.C.; Ma, Y.; Zak, Y.; Poultsides, G.A.; Norton, J.A.; Rhoads, K.F. Failure to comply with NCCN guidelines for the management of pancreatic cancer compromises outcomes. HPB 2012, 14, 539–547. [Google Scholar] [CrossRef]
- Lin, Y.J.; Burkhart, R.; Lu, T.P.; Wolfgang, C.; Wright, M.; Zheng, L.; Wu, H.Y.; Chen, C.H.; Lee, S.Y.; Wu, C.H.; et al. Solid Pseudopapillary Neoplasms of the Pancreas Across Races Demonstrate Disparities with Comparably Good Prognosis. World J. Surg. 2022, 46, 3072–3080. [Google Scholar] [CrossRef]
- Silverman, D.T.; Hoover, R.N.; Brown, L.M.; Swanson, G.M.; Schiffman, M.; Greenberg, R.S.; Hayes, R.B.; Lillemoe, K.D.; Schoenberg, J.B.; Schwartz, A.G.; et al. Why do Black Americans have a higher risk of pancreatic cancer than White Americans? Epidemiology 2003, 14, 45–54. [Google Scholar] [CrossRef]
- Fabregas, J.C.; Riley, K.E.; Brant, J.M.; George, T.J.; Orav, E.J.; Lam, M.B. Association of social determinants of health with late diagnosis and survival of patients with pancreatic cancer. J. Gastrointest. Oncol. 2022, 13, 1204–1214. [Google Scholar] [CrossRef]
- Hao, S.; Mitsakos, A.; Irish, W.; Tuttle-Newhall, J.E.; Parikh, A.A.; Snyder, R.A. Differences in receipt of multimodality therapy by race, insurance status, and socioeconomic disadvantage in patients with resected pancreatic cancer. J. Surg. Oncol. 2022, 126, 302–313. [Google Scholar] [CrossRef] [PubMed]
- Mehta, V.V.; Friedmann, P.; McAuliffe, J.C.; Muscarella, P., 2nd; In, H. Pancreatic Cancer Surgery Following Emergency Department Admission: Understanding Poor Outcomes and Disparities in Care. J. Gastrointest. Surg. 2021, 25, 1261–1270. [Google Scholar] [CrossRef] [PubMed]
- Riner, A.N.; Underwood, P.W.; Yang, K.; Herremans, K.M.; Cameron, M.E.; Chamala, S.; Qiu, P.; George, T.J.; Permuth, J.B.; Merchant, N.B.; et al. Disparities in Pancreatic Ductal Adenocarcinoma-The Significance of Hispanic Ethnicity, Subgroup Analysis, and Treatment Facility on Clinical Outcomes. Cancer Med. 2020, 9, 4069–4082. [Google Scholar] [CrossRef] [PubMed]
- Moaven, O.; Richman, J.S.; Reddy, S.; Wang, T.; Heslin, M.J.; Contreras, C.M. Healthcare disparities in outcomes of patients with resectable pancreatic cancer. Am. J. Surg. 2019, 217, 725–731. [Google Scholar] [CrossRef]
- Seyedin, S.; Luu, C.; Stabile, B.E.; Lee, B. Effect of socioeconomic status on surgery for pancreatic adenocarcinoma. Am. Surg. 2012, 78, 1128–1131. [Google Scholar] [CrossRef]
- Chang, C.M.; Su, Y.C.; Lai, N.S.; Huang, K.Y.; Chien, S.H.; Chang, Y.H.; Lian, W.C.; Hsu, T.W.; Lee, C.C. The combined effect of individual and neighborhood socioeconomic status on cancer survival rates. PLoS ONE 2012, 7, e44325. [Google Scholar] [CrossRef]
- Powell, C.B.; Laurent, C.; Garcia, C.; Hoodfar, E.; Karlea, A.; Kobelka, C.; Lee, J.; Roh, J.; Kushi, L.H. Factors influencing genetic counseling and testing for hereditary breast and ovarian cancer syndrome in a large US health care system. Clin. Genet. 2022, 101, 324–334. [Google Scholar] [CrossRef]
- Zavala, V.A.; Bracci, P.M.; Carethers, J.M.; Carvajal-Carmona, L.; Coggins, N.B.; Cruz-Correa, M.R.; Davis, M.; de Smith, A.J.; Dutil, J.; Figueiredo, J.C.; et al. Cancer health disparities in racial/ethnic minorities in the United States. Br. J. Cancer 2021, 124, 315–332. [Google Scholar] [CrossRef]
- Ashktorab, H.; Kupfer, S.S.; Brim, H.; Carethers, J.M. Racial Disparity in Gastrointestinal Cancer Risk. Gastroenterology 2017, 153, 910–923. [Google Scholar] [CrossRef]
- Liu, C.T.; Raghavan, S.; Maruthur, N.; Kabagambe, E.K.; Hong, J.; Ng, M.C.; Hivert, M.F.; Lu, Y.; An, P.; Bentley, A.R.; et al. Trans-ethnic Meta-analysis and Functional Annotation Illuminates the Genetic Architecture of Fasting Glucose and Insulin. Am. J. Hum. Genet. 2016, 99, 56–75. [Google Scholar] [CrossRef]
- Singal, V.; Singal, A.K.; Kuo, Y.F. Racial disparities in treatment for pancreatic cancer and impact on survival: A population-based analysis. J. Cancer Res. Clin. Oncol. 2012, 138, 715–722. [Google Scholar] [CrossRef] [PubMed]
- Gordon, D.R.; Radecki Breitkopf, C.; Robinson, M.; Petersen, W.O.; Egginton, J.S.; Chaffee, K.G.; Petersen, G.M.; Wolf, S.M.; Koenig, B.A. Should Researchers Offer Results to Family Members of Cancer Biobank Participants? A Mixed-Methods Study of Proband and Family Preferences. AJOB Empir. Bioeth. 2019, 10, 1–22. [Google Scholar] [CrossRef] [PubMed]
- Jackson, F.L. Illuminating cancer health disparities using ethnogenetic layering (EL) and phenotype segregation network analysis (PSNA). J. Cancer Educ. 2006, 21, S69–S79. [Google Scholar] [CrossRef] [PubMed]
- Mitsakos, A.T.; Dennis, S.O.; Parikh, A.A.; Snyder, R.A. Thirty-day complication rates do not differ by race among patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma. J. Surg. Oncol. 2021, 123, 970–977. [Google Scholar] [CrossRef]
- Salami, A.; Alvarez, N.H.; Joshi, A.R.T. Geographic disparities in surgical treatment recommendation patterns and survival for pancreatic adenocarcinoma. HPB 2017, 19, 1008–1015. [Google Scholar] [CrossRef]
- Abbott, D.E.; Martin, G.; Kooby, D.A.; Merchant, N.B.; Squires, M.H.; Maithel, S.K.; Weber, S.M.; Winslow, E.R.; Cho, C.S.; Bentrem, D.J.; et al. Perception Is Reality: Quality metrics in pancreas surgery—A Central Pancreas Consortium (CPC) analysis of 1399 patients. HPB 2016, 18, 462–469. [Google Scholar] [CrossRef]
- Diaz Osterman, C.J.; Gonda, A.; Stiff, T.; Sigaran, U.; Valenzuela, M.M.; Ferguson Bennit, H.R.; Moyron, R.B.; Khan, S.; Wall, N.R. Curcumin Induces Pancreatic Adenocarcinoma Cell Death Via Reduction of the Inhibitors of Apoptosis. Pancreas 2016, 45, 101–109. [Google Scholar] [CrossRef]
- Galloway, N.R.; Aspe, J.R.; Sellers, C.; Wall, N.R. Enhanced antitumor effect of combined gemcitabine and proton radiation in the treatment of pancreatic cancer. Pancreas 2009, 38, 782–790. [Google Scholar] [CrossRef]
- Gleason-Comstock, J.; Calhoun, C.B.; Mozeb, G.; Louis, C.; Hill, A.; Locke, B.J.; Harrell, V.; Yasmin, S.; Zhang, L.; Flack, J.M.; et al. Recruitment, Retention, and Future Direction for a Heart Health Education and Risk Reduction Intervention Led by Community Health Workers in an African American Majority City. J. Racial Ethn. Health Disparities 2023, 10, 1432–1440. [Google Scholar] [CrossRef]
- Joo, W.T. Educational gradient in social network changes at disease diagnosis. Soc. Sci. Med. 2023, 317, 115626. [Google Scholar] [CrossRef]
- Hall, J.M.; Chakrabarti, C.; Mkuu, R.; Thompson, L.A.; Shenkman, E.A.; Theis, R.P. The Association of Socioeconomic Vulnerability and Race and Ethnicity with Disease Burden among Children in a Statewide Medicaid Population. Acad. Pediatr. 2023, 23, 372–380. [Google Scholar] [CrossRef] [PubMed]
- Jones, B.L.; Carter, M.C.; Davis, C.M.; Wang, J. Diversity, Equity, and Inclusion: A Decade of Progress? J. Allergy Clin. Immunol. Pract. 2023, 11, 116–125. [Google Scholar] [CrossRef] [PubMed]
- Rafizadeh, E.B.; Rice, E.; Smith, J.; Bell, J.; Harvath, T.A. Understanding How Community Health Workers Build Trust with Low-Income Women of Color At-Risk for Maternal Child Health Disparities: A Grounded Theory Study. J. Community Health Nurs. 2023, 40, 219–231. [Google Scholar] [CrossRef] [PubMed]
- Kim, G.; Qin, J.; Hall, C.B.; In, H. Association Between Socioeconomic and Insurance Status and Delayed Diagnosis of Gastrointestinal Cancers. J. Surg. Res. 2022, 279, 170–186. [Google Scholar] [CrossRef]
- Zhu, F.; Wang, H.; Ashamalla, H. Racial and Socioeconomic Disparities in the Treatments and Outcomes of Pancreatic Cancer among Different Treatment Facility Types. Pancreas 2020, 49, 1355–1363. [Google Scholar] [CrossRef] [PubMed]
- Noel, M.; Fiscella, K. Disparities in Pancreatic Cancer Treatment and Outcomes. Health Equity 2019, 3, 532–540. [Google Scholar] [CrossRef]
- Vallance, A.E.; van der Meulen, J.; Kuryba, A.; Braun, M.; Jayne, D.G.; Hill, J.; Cameron, I.C.; Walker, K. Socioeconomic differences in selection for liver resection in metastatic colorectal cancer and the impact on survival. Eur. J. Surg. Oncol. 2018, 44, 1588–1594. [Google Scholar] [CrossRef]
- Shapiro, M.; Chen, Q.; Huang, Q.; Boosalis, V.A.; Yoon, C.H.; Saund, M.S.; Whang, E.E.; Gold, J.S. Associations of Socioeconomic Variables with Resection, Stage, and Survival in Patients with Early-Stage Pancreatic Cancer. JAMA Surg. 2016, 151, 338–345. [Google Scholar] [CrossRef]
- Bakens, M.; Lemmens, V.; de Hingh, I. Socio-economic status influences the likelihood of undergoing surgical treatment for pancreatic cancer in the Netherlands. HPB 2017, 19, 443–448. [Google Scholar] [CrossRef]
- Del Valle, J.P.; Fillmore, N.R.; Molina, G.; Fairweather, M.; Wang, J.; Clancy, T.E.; Ashley, S.W.; Urman, R.D.; Whang, E.E.; Gold, J.S. Socioeconomic Disparities in Pancreas Cancer Resection and Survival in the Veterans Health Administration. Ann. Surg. Oncol. 2022, 29, 3194–3202. [Google Scholar] [CrossRef]
- Gallegos, J.M.; Taylor, A.; Vardell, V.; Silberstein, P.T. Socioeconomic Factors Associated with a Late-Stage Pancreatic Cancer Diagnosis: An Analysis of the National Cancer Database. Cureus 2023, 15, e35857. [Google Scholar] [CrossRef] [PubMed]
- Torres, M.B.; Dixon, M.E.B.; Gusani, N.J. Undertreatment of Pancreatic Cancer: The Intersection of Bias, Biology, and Geography. Surg. Oncol. Clin. N. Am. 2022, 31, 43–54. [Google Scholar] [CrossRef] [PubMed]
- Underwood, P.W.; Riner, A.N.; Neal, D.; Cameron, M.E.; Yakovenko, A.; Reddy, S.; Rose, J.B.; Hughes, S.J.; Trevino, J.G. It’s more than just cancer biology: Health disparities in patients with pancreatic neuroendocrine tumors. J. Surg. Oncol. 2021, 124, 1390–1401. [Google Scholar] [CrossRef] [PubMed]
- Liu, J.H.; Zingmond, D.S.; McGory, M.L.; SooHoo, N.F.; Ettner, S.L.; Brook, R.H.; Ko, C.Y. Disparities in the utilization of high-volume hospitals for complex surgery. JAMA 2006, 296, 1973–1980. [Google Scholar] [CrossRef]
- Boonhat, H.; Pratama, A.P.; Lin, J.T.; Lin, R.T. Duration-response association between occupational exposure and pancreatic cancer risk: Meta-analysis. Occup. Med. 2023, 73, 211–218. [Google Scholar] [CrossRef]
- Kamendulis, L.M.; Hocevar, J.M.; Stephens, M.; Sandusky, G.E.; Hocevar, B.A. Exposure to perfluorooctanoic acid leads to promotion of pancreatic cancer. Carcinogenesis 2022, 43, 469–478. [Google Scholar] [CrossRef]
- Togawa, K.; Leon, M.E.; Lebailly, P.; Beane Freeman, L.E.; Nordby, K.C.; Baldi, I.; MacFarlane, E.; Shin, A.; Park, S.; Greenlee, R.T.; et al. Cancer incidence in agricultural workers: Findings from an international consortium of agricultural cohort studies (AGRICOH). Environ. Int. 2021, 157, 106825. [Google Scholar] [CrossRef]
- Endo, M.; Haruyama, Y.; Muto, G.; Kiyohara, K.; Mizoue, T.; Kojimahara, N.; Yamaguchi, N. Work Sustainability among Male Cancer Survivors after Returning to Work. J. Epidemiol. 2018, 28, 88–93. [Google Scholar] [CrossRef]
- de Boer, A.G.; Bruinvels, D.J.; Tytgat, K.M.; Schoorlemmer, A.; Klinkenbijl, J.H.; Frings-Dresen, M.H. Employment status and work-related problems of gastrointestinal cancer patients at diagnosis: A cross-sectional study. BMJ Open 2011, 1, e000190. [Google Scholar] [CrossRef]
- Zaitsu, M.; Kim, Y.; Lee, H.E.; Takeuchi, T.; Kobayashi, Y.; Kawachi, I. Occupational class differences in pancreatic cancer survival: A population-based cancer registry-based study in Japan. Cancer Med. 2019, 8, 3261–3268. [Google Scholar] [CrossRef]
- Munigala, S.; Gardner, T.B.; O’Reilly, E.M.; Fernandez-Del Castillo, C.; Ko, A.H.; Pleskow, D.; Vollmer, C.M., Jr.; Searle, N.A.; Bakelman, D.; Holt, J.M.; et al. Helping Patients Understand Pancreatic Cancer Using Animated Pancreas Patient Education with Visual Formats of Learning. Pancreas 2022, 51, 628–633. [Google Scholar] [CrossRef] [PubMed]
- Humphrys, E.; Burt, J.; Rubin, G.; Emery, J.D.; Walter, F.M. The influence of health literacy on the timely diagnosis of symptomatic cancer: A systematic review. Eur. J. Cancer Care 2019, 28, e12920. [Google Scholar] [CrossRef] [PubMed]
- Munigala, S.; Gardner, T.B.; O’Reilly, E.M.; Castillo, C.F.; Ko, A.H.; Pleskow, D.; Mills, J.B.; Vollmer, C.M., Jr.; Searle, N.A.; Alsante, M.; et al. Understanding Pancreatic Diseases Using Animated Pancreas Patient: Informing Patients for Better Health Outcomes with Visual Formats of Learning. Pancreas 2018, 47, 1256–1261. [Google Scholar] [CrossRef] [PubMed]
- Garland, M.E.; Lukac, D.; Contreras, P. A Brief Report: Comparative Evaluation of Online Spanish and English Content on Pancreatic Cancer Treatment. J. Cancer Educ. 2023, 38, 664–668. [Google Scholar] [CrossRef]
- Riner, A.N.; Girma, S.; Vudatha, V.; Mukhopadhyay, N.; Skoro, N.; Gal, T.S.; Freudenberger, D.C.; Herremans, K.M.; George, T.J.; Trevino, J.G. Eligibility Criteria Perpetuate Disparities in Enrollment and Participation of Black Patients in Pancreatic Cancer Clinical Trials. J. Clin. Oncol. 2022, 40, 2193–2202. [Google Scholar] [CrossRef]
- Paltoo, D.N.; Chu, K.C. Patterns in cancer incidence among American Indians/Alaska Natives, United States, 1992–1999. Public Health Rep. 2004, 119, 443–451. [Google Scholar] [CrossRef]
- Francis, D.B.; Zelaya, C.M. Cancer Fatalism and Cancer Information Seeking among Black Women: Examining the Impact of Aretha Franklin’s Death on Cancer Communication Outcomes. J. Cancer Educ. 2021, 36, 763–768. [Google Scholar] [CrossRef]
- Rauscher, E.A.; Dean, M.; Campbell-Salome, G.M. “I Am Uncertain about What My Uncertainty Even Is”: Men’s Uncertainty and Information Management of Their BRCA-Related Cancer Risks. J. Genet. Couns. 2018, 27, 1417–1427. [Google Scholar] [CrossRef]
- Foroughi, F.; Lam, A.K.; Lim, M.S.C.; Saremi, N.; Ahmadvand, A. “Googling” for Cancer: An Infodemiological Assessment of Online Search Interests in Australia, Canada, New Zealand, the United Kingdom, and the United States. JMIR Cancer 2016, 2, e5. [Google Scholar] [CrossRef]
- Kim, N.; Kang, D.; Shin, S.H.; Heo, J.S.; Shim, S.; Lim, J.; Cho, J.; Han, I.W. Effects of cancer stigma on quality of life of patients with hepatobiliary and pancreatic cancer. Ann. Hepatobiliary Pancreat Surg. 2023, 27, 172–179. [Google Scholar] [CrossRef]
- Warner, E.T.; Park, E.R.; Luberto, C.M.; Rabin, J.; Perez, G.K.; Ostroff, J.S. Internalized stigma among cancer patients enrolled in a smoking cessation trial: The role of cancer type and associations with psychological distress. Psychooncology 2022, 31, 753–760. [Google Scholar] [CrossRef] [PubMed]
- Cabasag, C.J.; Arnold, M.; Pineros, M.; Morgan, E.; Brierley, J.; Hofferkamp, J.; Kehoe, S.; Butler, J.; Bucher, O.; Bray, F.; et al. Population-based cancer staging for oesophageal, gastric, and pancreatic cancer 2012–2014: International Cancer Benchmarking Partnership SurvMark-2. Int. J. Cancer 2021, 149, 1239–1246. [Google Scholar] [CrossRef]
- Tang, D.; Tang, Q.; Huang, W.; Zhang, Y.; Tian, Y.; Fu, X. Fasting: From Physiology to Pathology. Adv. Sci. 2023, 10, e2204487. [Google Scholar] [CrossRef] [PubMed]
- Jiang, Y.; Sohal, D.P.S. Pancreatic Adenocarcinoma Management. JCO Oncol. Pract. 2023, 19, 19–32. [Google Scholar] [CrossRef] [PubMed]
- Chung, V.; Sun, V.; Ruel, N.; Smith, T.J.; Ferrell, B.R. Improving Palliative Care and Quality of Life in Pancreatic Cancer Patients. J. Palliat. Med. 2022, 25, 720–727. [Google Scholar] [CrossRef] [PubMed]
- Park, S.; Ortega, A.N.; Chen, J.; Bustamante, A.V. Effects of Medicare eligibility and enrollment at age 65 among immigrants and US-born residents. J. Am. Geriatr. Soc. 2023, 71, 2845–2854. [Google Scholar] [CrossRef] [PubMed]
- Malagon, T.; Morais, S.; Tope, P.; El-Zein, M.; Franco, E.L. Site-specific cancer incidence by race and immigration status in Canada 2006-2015: A population-based data linkage study. Cancer Epidemiol. Biomark. Prev. 2023, 32, 906–918. [Google Scholar] [CrossRef] [PubMed]
- La Frinere-Sandoval, Q.; Cubbin, C.; DiNitto, D.M. Racial and ethnic disparities in cervical and breast cancer screenings by nativity and length of U.S. residence. Ethn. Health 2023, 28, 895–911. [Google Scholar] [CrossRef]
- Murrar, S.; Baqai, B.; Padela, A.I. Predictors of Perceived Discrimination in Medical Settings among Muslim Women in the USA. J. Racial Ethn. Health Disparities 2023, 1–7. [Google Scholar] [CrossRef]
- Zhang, M.; Sit, J.W.H.; Choi, K.C.; Chan, C.W.H. A theory-driven, culture-tailored educational intervention for cervical cancer screening among rural Chinese females: A feasibility and pilot study. Asia Pac. J. Oncol. Nurs. 2023, 10, 100218. [Google Scholar] [CrossRef]
- Mishra, S.I.; Adsul, P.; Leekity, S.; Rodman, J.; Sussman, A.L.; Kelly, K.; Sheche, J.; Faber, T.; Shah, V. A culturally informed model to enhance breast, cervical, and colorectal cancer screenings: Perspectives of American Indian adults and healthcare providers in rural New Mexico. Cancer Causes Control 2023, 34, 855–871. [Google Scholar] [CrossRef]
- Roh, S.; Lee, Y.S. Developing Culturally Tailored Mobile Web App Education to Promote Breast Cancer Screening: Knowledge, Barriers, and Needs among American Indian Women. J. Cancer Educ. 2023, 38, 1224–1233. [Google Scholar] [CrossRef]
- Richardson-Parry, A.; Silva, M.; Valderas, J.M.; Donde, S.; Woodruff, S.; van Vugt, J. Interactive or tailored digital interventions to increase uptake in cervical, breast, and colorectal cancer screening to reduce health inequity: A systematic review. Eur. J. Cancer Prev. 2023, 32, 396–409. [Google Scholar] [CrossRef]
- Cobianchi, L.; Dal Mas, F.; Denicolai, S.; Previtali, P.; Venturi, A. Editorial: New frontiers in pancreatic cancer care: Multidisciplinary approaches, the role of Pancreas Units, and their organizational impacts. Front. Surg. 2023, 10, 1182206. [Google Scholar] [CrossRef] [PubMed]
- Kolbeinsson, H.M.; Chandana, S.; Wright, G.P.; Chung, M. Pancreatic Cancer: A Review of Current Treatment and Novel Therapies. J. Investig. Surg. 2023, 36, 2129884. [Google Scholar] [CrossRef] [PubMed]
- Khan, N.N.; Evans, S.M.; Ioannou, L.J.; Pilgrim, C.H.C.; Blanchard, M.; Daveson, B.; Philip, J.; Zalcberg, J.R.; Te Marvelde, L. Characteristics of patients diagnosed with pancreatic cancer who access palliative care: An observational study. Qual. Life Res. 2023, 32, 2617–2627. [Google Scholar] [CrossRef] [PubMed]
- Soreide, K.; Ismail, W.; Roalso, M.; Ghotbi, J.; Zaharia, C. Early Diagnosis of Pancreatic Cancer: Clinical Premonitions, Timely Precursor Detection and Increased Curative-Intent Surgery. Cancer Control 2023, 30, 1–14. [Google Scholar] [CrossRef] [PubMed]
- Digiacomo, L.; Quagliarini, E.; Pozzi, D.; Coppola, R.; Caracciolo, G.; Caputo, D. Stratifying Risk for Pancreatic Cancer by Multiplexed Blood Test. Cancers 2023, 15, 2983. [Google Scholar] [CrossRef]
- He, Y.; Huang, W.; Tang, Y.; Li, Y.; Peng, X.; Li, J.; Wu, J.; You, N.; Li, L.; Liu, C.; et al. Clinical and genetic characteristics in pancreatic cancer from Chinese patients revealed by whole exome sequencing. Front. Oncol. 2023, 13, 1167144. [Google Scholar] [CrossRef]
- Huang, Y.; Zhou, S.; Luo, Y.; Zou, J.; Li, Y.; Chen, S.; Gao, M.; Huang, K.; Lian, G. Development and validation of a radiomics model of magnetic resonance for predicting liver metastasis in resectable pancreatic ductal adenocarcinoma patients. Radiat. Oncol. 2023, 18, 79. [Google Scholar] [CrossRef]
- Li, J.; Huang, L.; Liao, C.; Liu, G.; Tian, Y.; Chen, S. Two machine learning-based nomogram to predict risk and prognostic factors for liver metastasis from pancreatic neuroendocrine tumors: A multicenter study. BMC Cancer 2023, 23, 529. [Google Scholar] [CrossRef] [PubMed]
- Lippman, S.M.; Abate-Shen, C.; Colbert Maresso, K.L.; Colditz, G.A.; Dannenberg, A.J.; Davidson, N.E.; Disis, M.L.; DuBois, R.N.; Szabo, E.; Giuliano, A.R.; et al. AACR White Paper: Shaping the Future of Cancer Prevention—A Roadmap for Advancing Science and Public Health. Cancer Prev. Res. 2018, 11, 735–778. [Google Scholar] [CrossRef] [PubMed]
- Han, X.; Zhao, J.; Yabroff, K.R.; Johnson, C.J.; Jemal, A. Association Between Medicaid Expansion under the Affordable Care Act and Survival among Newly Diagnosed Cancer Patients. J. Natl. Cancer Inst. 2022, 114, 1176–1185. [Google Scholar] [CrossRef] [PubMed]
- Mellado, S.; Vega, E.A.; Abudalou, M.; Kutlu, O.C.; Salehi, O.; Li, M.; Kozyreva, O.; Freeman, R.; Conrad, C. Trends in Preoperative Chemotherapy Utilization for Proximal Pancreatic Cancer: Are We Making Progress? J. Gastrointest. Surg. 2022, 26, 1–7. [Google Scholar] [CrossRef]
- Ueberroth, B.E.; Khan, A.; Zhang, K.J.; Philip, P.A. Differences in Baseline Characteristics and White Blood Cell Ratios Between Racial Groups in Patients with Pancreatic Adenocarcinoma. J. Gastrointest. Cancer 2021, 52, 160–168. [Google Scholar] [CrossRef]
- Robbins, H.A.; Engels, E.A.; Pfeiffer, R.M.; Shiels, M.S. Age at cancer diagnosis for blacks compared with whites in the United States. J. Natl. Cancer Inst. 2015, 107, 489. [Google Scholar] [CrossRef]
- Macklin-Mantia, S.K.; Clift, K.E.; Maimone, S.; Hodge, D.O.; Riegert-Johnson, D.; Hines, S.L. Patient uptake of updated genetic testing following uninformative BRCA1 and BRCA2 results. J. Genet. Couns. 2023, 32, 598–606. [Google Scholar] [CrossRef]
- Zhu, H.; Welinsky, S.; Soper, E.R.; Brown, K.L.; Abul-Husn, N.S.; Lucas, A.L. Genetic Variants in Patients with a Family History of Pancreatic Cancer: Impact of Multigene Panel Testing. Pancreas 2021, 50, 602–606. [Google Scholar] [CrossRef]
- Abe, K.; Ueki, A.; Urakawa, Y.; Kitago, M.; Yoshihama, T.; Nanki, Y.; Kitagawa, Y.; Aoki, D.; Kosaki, K.; Hirasawa, A. Familial pancreatic cancer with PALB2 and NBN pathogenic variants: A case report. Hered. Cancer Clin. Pract. 2021, 19, 5. [Google Scholar] [CrossRef]
- Nakamura, K.; Zhu, Z.; Roy, S.; Jun, E.; Han, H.; Munoz, R.M.; Nishiwada, S.; Sharma, G.; Cridebring, D.; Zenhausern, F.; et al. An Exosome-based Transcriptomic Signature for Noninvasive, Early Detection of Patients with Pancreatic Ductal Adenocarcinoma: A Multicenter Cohort Study. Gastroenterology 2022, 163, 1252–1266.e2. [Google Scholar] [CrossRef]
- Chung, C.; Galvin, R.; Achenbach, E.; Dziadkowiec, O.; Sen, S. Characterization of Blood-Based Molecular Profiling in Pancreatic Adenocarcinoma. Oncology 2021, 35, 794–803. [Google Scholar] [CrossRef] [PubMed]
- Donahue, T.R.; Tran, L.M.; Hill, R.; Li, Y.; Kovochich, A.; Calvopina, J.H.; Patel, S.G.; Wu, N.; Hindoyan, A.; Farrell, J.J.; et al. Integrative survival-based molecular profiling of human pancreatic cancer. Clin. Cancer Res. 2012, 18, 1352–1363. [Google Scholar] [CrossRef] [PubMed]
- Zou, Y.; Pitchumoni, C.S. Obesity, obesities and gastrointestinal cancers. Dis. Mon. 2023, 101592. [Google Scholar] [CrossRef]
- Neumann, C.C.M.; Schneider, F.; Hilfenhaus, G.; Vecchione, L.; Benzing, C.; Ihlow, J.; Fehrenbach, U.; Malinka, T.; Keilholz, U.; Stintzing, S.; et al. Impact of Smoking, Body Weight, Diabetes, Hypertension and Kidney Dysfunction on Survival in Pancreatic Cancer Patients-A Single Center Analysis of 2323 Patients within the Last Decade. J. Clin. Med. 2023, 12, 3656. [Google Scholar] [CrossRef]
- Nodari, Y.; Gentiluomo, M.; Mohelnikova-Duchonova, B.; Kreivenaite, E.; Milanetto, A.C.; Skieceviciene, J.; Landi, S.; Lawlor, R.T.; Petrone, M.C.; Arcidiacono, P.G.; et al. Genetic and non-genetic risk factors for early-onset pancreatic cancer. Dig. Liver Dis. 2023, 55, 1417–1425. [Google Scholar] [CrossRef]
- Perez-Diez, I.; Andreu, Z.; Hidalgo, M.R.; Perpina-Clerigues, C.; Fantin, L.; Fernandez-Serra, A.; de la Iglesia-Vaya, M.; Lopez-Guerrero, J.A.; Garcia-Garcia, F. A Comprehensive Transcriptional Signature in Pancreatic Ductal Adenocarcinoma Reveals New Insights into the Immune and Desmoplastic Microenvironments. Cancers 2023, 15, 2887. [Google Scholar] [CrossRef]
- Osman, K.; Ahmet, K.; Hilmi, T.; Ilker, N.O.; Ercan, O.; Devrim, C.; Murat, S.; Emre, C.; Ilhan, H.; Mustafa, G.; et al. BRCA 1/BRCA 2 Pathogenic/Likely Pathogenic Variant Patients with Breast, Ovarian, and Other Cancers. Balk. J. Med. Genet. 2023, 25, 5–14. [Google Scholar] [CrossRef] [PubMed]
- Clark, N.M.; Roberts, E.A.; Fedorenko, C.; Sun, Q.; Dubard-Gault, M.; Handford, C.; Yung, R.; Cheng, H.H.; Sham, J.G.; Norquist, B.M.; et al. Genetic Testing among Patients with High-Risk Breast, Ovarian, Pancreatic, and Prostate Cancers. Ann. Surg. Oncol. 2023, 30, 1312–1326. [Google Scholar] [CrossRef]
- Everett, J.N.; Dettwyler, S.A.; Jing, X.; Stender, C.; Schmitter, M.; Baptiste, A.; Chun, J.; Kawaler, E.A.; Khanna, L.G.; Gross, S.A.; et al. Impact of comprehensive family history and genetic analysis in the multidisciplinary pancreatic tumor clinic setting. Cancer Med. 2023, 12, 2345–2355. [Google Scholar] [CrossRef]
- Dayyani, F.; Macarulla, T.; Johnson, A.; Wainberg, Z.A. Second-line treatment options for patients with metastatic pancreatic ductal adenocarcinoma: A systematic literature review. Cancer Treat. Rev. 2023, 113, 102502. [Google Scholar] [CrossRef]
- Kitamura, H.; Nakazawa, J.; Nagashima, F.; Andou, M.; Furuse, J. The Prognostic Utility of a Geriatric Assessment for Patients with Pancreatic Cancer Receiving Gemcitabine-based Chemotherapy: A Prospective Observational Study. Intern. Med. 2023, 62, 1573–1580. [Google Scholar] [CrossRef]
- Farrell, J.J.; Robert, M.E.; Lacy, J. Precision Medicine for Pancreas Cancer Treatment: A Multidisciplinary Challenge or Opportunity? Clin. Gastroenterol. Hepatol. 2023, 21, 2740–2742. [Google Scholar] [CrossRef] [PubMed]
- Molnar, A.; Monroe, H.; Basri Aydin, H.; Arslan, M.E.; Lightle, A.; Lee, H.; El Jabbour, T. Tumors of the Digestive System: Comprehensive Review of Ancillary Testing and Biomarkers in the Era of Precision Medicine. Curr. Oncol. 2023, 30, 2388–2404. [Google Scholar] [CrossRef] [PubMed]
- Sereti, E.; Papapostolou, I.; Dimas, K. Pancreatic Cancer Organoids: An Emerging Platform for Precision Medicine? Biomedicines 2023, 11, 890. [Google Scholar] [CrossRef] [PubMed]
- Belleau, P.; Deschenes, A.; Chambwe, N.; Tuveson, D.A.; Krasnitz, A. Genetic Ancestry Inference from Cancer-Derived Molecular Data across Genomic and Transcriptomic Platforms. Cancer Res. 2023, 83, 49–58. [Google Scholar] [CrossRef]
- Hamada, T.; Yuan, C.; Yurgelun, M.B.; Perez, K.; Khalaf, N.; Morales-Oyarvide, V.; Babic, A.; Nowak, J.A.; Rubinson, D.A.; Giannakis, M.; et al. Family history of cancer, Ashkenazi Jewish ancestry, and pancreatic cancer risk. Br. J. Cancer 2019, 120, 848–854. [Google Scholar] [CrossRef]
- Adams, A.M.; Reames, B.N.; Krell, R.W. Morbidity and Mortality of Non-pancreatectomy operations for pancreatic cancer: An ACS-NSQIP analysis. Am. J. Surg. 2023, 225, 315–321. [Google Scholar] [CrossRef]
- Fraumeni, J.F., Jr. Cancers of the pancreas and biliary tract: Epidemiological considerations. Cancer Res. 1975, 35, 3437–3446. [Google Scholar]
- Del Nero, L.; Dabizzi, E.; Ceglie, A.; Ziola, S.; Zerbi, A.; Baron, T.H.; Conio, M. Familial pancreatic cancer. Clin. Res. Hepatol. Gastroenterol. 2023, 47, 102079. [Google Scholar] [CrossRef]
- Amaral, M.J.; Oliveira, R.C.; Donato, P.; Tralhao, J.G. Pancreatic Cancer Biomarkers: Oncogenic Mutations, Tissue and Liquid Biopsies, and Radiomics-A Review. Dig. Dis. Sci. 2023, 68, 2811–2823. [Google Scholar] [CrossRef]
- Balzano, G.; Guarneri, G.; Pecorelli, N.; Partelli, S.; Crippa, S.; Vico, A.; Falconi, M.; Baglio, G. Geographical Disparities and Patients’ Mobility: A Plea for Regionalization of Pancreatic Surgery in Italy. Cancers 2023, 15, 2429. [Google Scholar] [CrossRef]
- Calvillo-Ortiz, R.; Polanco-Santana, J.C.; Castillo-Angeles, M.; Allar, B.G.; Anguiano-Landa, L.; Ghaffarpasand, E.; Barrows, C.; Callery, M.P.; Kent, T.S. Language Proficiency and Survival in Pancreatic Cancer: A Propensity Score-Matched Analysis. J. Gastrointest. Surg. 2022, 26, 94–103. [Google Scholar] [CrossRef]
- Mobley, E.M.; Guerrier, C.; Tfirn, I.; Gutter, M.S.; Vigal, K.; Pather, K.; Braithwaite, D.; Nataliansyah, M.M.; Tsai, S.; Baskovich, B.; et al. Impact of Medicaid Expansion on Stage at Diagnosis for US Adults with Pancreatic Cancer: A Population-Based Study. J. Racial Ethn. Health Disparities 2023. [Google Scholar] [CrossRef]
- Fong, Z.V.; Teinor, J.; Yeo, T.P.; Rinaldi, D.; Greer, J.B.; Lavu, H.; Qadan, M.; Johnston, F.M.; Ferrone, C.R.; Chang, D.C.; et al. Profile of the Postoperative Care Provided for Patients with Pancreatic and Periampullary Cancers by Family and Unpaid Caregivers. JCO Oncol. Pract. 2023, 19, 551–559. [Google Scholar] [CrossRef]
- Permuth, J.B.; Clark Daly, A.; Jeong, D.; Choi, J.W.; Cameron, M.E.; Chen, D.T.; Teer, J.K.; Barnett, T.E.; Li, J.; Powers, B.D.; et al. Racial and ethnic disparities in a state-wide registry of patients with pancreatic cancer and an exploratory investigation of cancer cachexia as a contributor to observed inequities. Cancer Med. 2019, 8, 3314–3324. [Google Scholar] [CrossRef] [PubMed]
- Bogumil, D.; Conti, D.V.; Sheng, X.; Xia, L.; Shu, X.O.; Pandol, S.J.; Blot, W.J.; Zheng, W.; Le Marchand, L.; Haiman, C.A.; et al. Replication and Genetic Risk Score Analysis for Pancreatic Cancer in a Diverse Multiethnic Population. Cancer Epidemiol. Biomark. Prev. 2020, 29, 2686–2692. [Google Scholar] [CrossRef] [PubMed]
- Hiltemann, S.; Rasche, H.; Gladman, S.; Hotz, H.R.; Lariviere, D.; Blankenberg, D.; Jagtap, P.D.; Wollmann, T.; Bretaudeau, A.; Goue, N.; et al. Galaxy Training: A powerful framework for teaching! PLoS Comput. Biol. 2023, 19, e1010752. [Google Scholar] [CrossRef] [PubMed]
- van der Horst, D.E.M.; Garvelink, M.M.; Bos, W.J.W.; Stiggelbout, A.M.; Pieterse, A.H. For which decisions is Shared Decision Making considered appropriate?—A systematic review. Patient Educ. Couns. 2023, 106, 3–16. [Google Scholar] [CrossRef]
- Freund, K.M.; Reisinger, S.A.; LeClair, A.M.; Yoon, G.H.; Al-Najar, S.M.; Young, G.S.; Gonzalez, E.T.; Oliveri, J.M.; Paskett, E.D. Insurance Stability and Cancer Screening Behaviors. Health Equity 2019, 3, 177–182. [Google Scholar] [CrossRef]
- Karagoz, M.A.; Sarica, K. Patient compliance to dietary recommendations: Tips and tricks to improve compliance rates. World J. Urol. 2023, 41, 1261–1268. [Google Scholar] [CrossRef]
- Shahid, S.; Durey, A.; Bessarab, D.; Aoun, S.M.; Thompson, S.C. Identifying barriers and improving communication between cancer service providers and Aboriginal patients and their families: The perspective of service providers. BMC Health Serv. Res. 2013, 13, 460. [Google Scholar] [CrossRef] [PubMed]
- Landers, A.; McKenzie, C.; Pitama, S.G.; Brown, H. Enzyme replacement in advanced pancreatic cancer: Patient perceptions. BMJ Support. Palliat. Care 2020, 13. [Google Scholar] [CrossRef] [PubMed]
- Andersson, T.K.; Engstrom, M.; Bjersa, K. Perceptions of Experiences of Recovery after Pancreaticoduodenectomy-A Phenomenographic Interview Study. Cancer Nurs. 2022, 45, 172–180. [Google Scholar] [CrossRef]
- Schildmann, J.; Ritter, P.; Salloch, S.; Uhl, W.; Vollmann, J. ‘One also needs a bit of trust in the doctor... ’: A qualitative interview study with pancreatic cancer patients about their perceptions and views on information and treatment decision-making. Ann. Oncol. 2013, 24, 2444–2449. [Google Scholar] [CrossRef] [PubMed]
- Weisburger, J.H. Approaches for chronic disease prevention based on current understanding of underlying mechanisms. Am. J. Clin. Nutr. 2000, 71, 1710S–1714S; discussion 1715S–1719S. [Google Scholar] [CrossRef] [PubMed]
- Eigenschink, M.; Bellach, L.; Leonard, S.; Dablander, T.E.; Maier, J.; Dablander, F.; Sitte, H.H. Cross-sectional survey and Bayesian network model analysis of traditional Chinese medicine in Austria: Investigating public awareness, usage determinants and perception of scientific support. BMJ Open 2023, 13, e060644. [Google Scholar] [CrossRef]
- Ikemoto, T.; Sugimoto, K.; Takita, M.; Shimoda, M.; Noguchi, H.; Naziruddin, B.; Levy, M.F.; Shimada, M.; Matsumoto, S. Japanese herbal medicine TJ-48 prevents autoimmune diabetes in NOD mice. Am. J. Chin. Med. 2011, 39, 743–756. [Google Scholar] [CrossRef]
- Li, L.; Leung, P.S. Use of herbal medicines and natural products: An alternative approach to overcoming the apoptotic resistance of pancreatic cancer. Int. J. Biochem. Cell Biol. 2014, 53, 224–236. [Google Scholar] [CrossRef]
- Nie, J.; Zhao, C.; Deng, L.I.; Chen, J.; Yu, B.; Wu, X.; Pang, P.; Chen, X. Efficacy of traditional Chinese medicine in treating cancer. Biomed. Rep. 2016, 4, 3–14. [Google Scholar] [CrossRef]
- Bigelsen, S. Evidence-based complementary treatment of pancreatic cancer: A review of adjunct therapies including paricalcitol, hydroxychloroquine, intravenous vitamin C, statins, metformin, curcumin, and aspirin. Cancer Manag. Res. 2018, 10, 2003–2018. [Google Scholar] [CrossRef]
- Gao, J.J.; Song, P.P.; Qi, F.H.; Kokudo, N.; Qu, X.J.; Tang, W. Evidence-based research on traditional Japanese medicine, Kampo, in treatment of gastrointestinal cancer in Japan. Drug. Discov. Ther. 2012, 6, 1–8. [Google Scholar] [CrossRef]
- Valenzuela, R.; Morales, A.; Sheen, J.; Rangel, S.; Salinas, J.J. The Implementation of Evidence-Based Obesity Education Curricula to Prevent Cancer in a Predominantly Mexican-American Community on the U.S.-Mexico Border. J. Cancer Educ. 2023, 38, 215–224. [Google Scholar] [CrossRef]
- Ai, A.L.; McCormick, T.R. Increasing diversity of Americans’ faiths alongside Baby Boomers’ aging: Implications for chaplain intervention in health settings. J. Health Care Chaplain. 2009, 16, 24–41. [Google Scholar] [CrossRef]
- Jaap, K.; Fluck, M.; Hunsinger, M.; Wild, J.; Arora, T.; Shabahang, M.; Blansfield, J. Analyzing the Impact of Compliance with National Guidelines for Pancreatic Cancer Care Using the National Cancer Database. J. Gastrointest. Surg. 2018, 22, 1358–1364. [Google Scholar] [CrossRef]
- Li, J.A.; Wu, W.C.; Ji, Y.; Liu, L.X.; Rao, S.X.; Wang, D.S.; Zhang, Y.Q.; Yao, X.Z.; Fan, Y.; Huang, C.; et al. Diagnostic value and patient compliance of a pancreas-oriented multidisciplinary clinic: A retrospective analysis from a Chinese pancreatic disease center. Zhonghua Wai Ke Za Zhi 2019, 57, 912–916. [Google Scholar] [CrossRef] [PubMed]
- Li, J.A.; Xu, Y.L.; Ding, N.; Ji, Y.; Liu, L.X.; Rao, S.X.; Zhang, Y.Q.; Yao, X.Z.; Fan, Y.; Huang, C.; et al. Pancreas multidisciplinary team optimizes the diagnosis and treatment of pancreas-related diseases and improves the prognosis of pancreatic cancer patients. Zhonghua Wai Ke Za Zhi 2022, 60, 666–673. [Google Scholar] [CrossRef] [PubMed]
- Sheni, R.; Qin, J.; Viswanathan, S.; Castellucci, E.; Kalnicki, S.; Mehta, V. Predictive Factors for Cancer Treatment Delay in a Racially Diverse and Socioeconomically Disadvantaged Urban Population. JCO Oncol. Pract. 2023, 19, e904–e915. [Google Scholar] [CrossRef]
- Lee, H.J., Jr.; Qian, C.L.; Landay, S.L.; O’Callaghan, D.; Kaslow-Zieve, E.; Azoba, C.C.; Fuh, C.X.; Temel, B.; Ufere, N.; Petrillo, L.A.; et al. Communicating the Information Needed for Treatment Decision Making among Patients with Pancreatic Cancer Receiving Preoperative Therapy. JCO Oncol. Pract. 2022, 18, e313–e324. [Google Scholar] [CrossRef] [PubMed]
- Haragi, M.; Hayakawa, M.; Watanabe, O.; Takayama, T. An exploratory study of the efficacy of medical illustration detail for delivering cancer information. J. Vis. Commun. Med. 2021, 44, 2–11. [Google Scholar] [CrossRef] [PubMed]
- Santos, L.G.; Buzdnitskaya, T.; Rolf, B.A.; Souza, W.; Sienko, M.; Ruiz-Bonilla, J.A.; Shah, B.; Jewell, P.; Jensen, L.; Horike-Pyne, M.; et al. Assessment of a Peer Physician Coaching Partnership between a Designated Cancer Center Genetics Service and a Community Cancer Network Hospital. JAMA Netw. Open 2023, 6, e231723. [Google Scholar] [CrossRef] [PubMed]
- Wong, E.C.; Torres, V.N.; Martinez, M.O.; Han, B.; Vue, M.; Derose, K.P. A parish-based multilevel cluster randomized controlled trial to reduce stigma and mental health treatment disparities among Latino communities. Contemp. Clin. Trials 2023, 125, 107080. [Google Scholar] [CrossRef] [PubMed]
- Collett, L.K.; Hudson, L.; Prichard, C.; Vanderford, N.L. Using Culturally Focused Storytelling to Empower Appalachian Kentucky Youth to Understand and Address Cancer Disparities in Their Communities. J. Cancer Educ. 2023, 38, 513–521. [Google Scholar] [CrossRef] [PubMed]
- Seo, J.Y.; Park, S.H.; Choi, S.E.; Lee, M.; Strauss, S.M. Development and Modification of a Culturally Tailored Education Program to Prevent Breast Cancer in Korean Immigrant Women in New York City. J. Cancer Educ. 2023, 38, 913–923. [Google Scholar] [CrossRef] [PubMed]
- Waterbor, J.W.; Adams, R.M.; Robinson, J.M.; Crabtree, F.G.; Accortt, N.A.; Gilliland, J. Disparities between public health educational materials and the scientific evidence that smokeless tobacco use causes cancer. J. Cancer Educ. 2004, 19, 17–28. [Google Scholar] [CrossRef] [PubMed]
- El Miedany, Y. MABS: Targeted therapy tailored to the patient’s need. Br. J. Nurs. 2015, 24, S4–S13. [Google Scholar] [CrossRef]
- Tung, H.F.; Chen, Y.L.; Chen, C.L.; Gee, M.J.; Muo, C.H.; Chiu, S.L. How Cultural Behaviors and Superstitions Associate the Willingness to Undergo Cataract Surgery in Taiwan: A Nationwide Survey. Medicina 2023, 59, 973. [Google Scholar] [CrossRef]
- Seppala, T.T.; Burkhart, R.A.; Katona, B.W. Hereditary colorectal, gastric, and pancreatic cancer: Comprehensive review. BJS Open 2023, 7, zrad023. [Google Scholar] [CrossRef]
- Chapple, A.; Evans, J.; McPherson, A.; Payne, S. Patients with pancreatic cancer and relatives talk about preferred place of death and what influenced their preferences: A qualitative study. BMJ Support. Palliat. Care 2011, 1, 291–295. [Google Scholar] [CrossRef]
- Taylor, A.K.; Chang, D.; Chew-Graham, C.; Rimmer, L.; Kausar, A. ‘It’s always in the back of my mind’: Understanding the psychological impact of recovery following pancreaticoduodenectomy for cancer: A qualitative study. BMJ Open 2021, 11, e050016. [Google Scholar] [CrossRef]
- Kummer, S.; Walter, F.M.; Chilcot, J.; Emery, J.; Sutton, S.; Scott, S.E. Do cognitive heuristics underpin symptom appraisal for symptoms of cancer?: A secondary qualitative analysis across seven cancers. Psychooncology 2019, 28, 1041–1047. [Google Scholar] [CrossRef]
- Coleman, J.; Olsen, S.J.; Sauter, P.K.; Baker, D.; Hodgin, M.B.; Stanfield, C.; Emerling, A.; Hruban, R.H.; Nolan, M.T. The effect of a Frequently Asked Questions module on a pancreatic cancer Web site patient/family chat room. Cancer Nurs. 2005, 28, 460–468. [Google Scholar] [CrossRef]
- Gagliardi, A.R.; Webster, F.; Brouwers, M.C.; Baxter, N.N.; Finelli, A.; Gallinger, S. How does context influence collaborative decision-making for health services planning, delivery and evaluation? BMC Health Serv. Res. 2014, 14, 545. [Google Scholar] [CrossRef] [PubMed]
- Hurdle, V.; Ouellet, J.F.; Dixon, E.; Howard, T.J.; Lillemoe, K.D.; Vollmer, C.M.; Sutherland, F.R.; Ball, C.G. Does regional variation impact decision-making in the management and palliation of pancreatic head adenocarcinoma? Results from an international survey. Can. J. Surg. 2014, 57, E69–E74. [Google Scholar] [CrossRef] [PubMed]
- Mills, K.; Birt, L.; Emery, J.D.; Hall, N.; Banks, J.; Johnson, M.; Lancaster, J.; Hamilton, W.; Rubin, G.P.; Walter, F.M. Understanding symptom appraisal and help-seeking in people with symptoms suggestive of pancreatic cancer: A qualitative study. BMJ Open 2017, 7, e015682. [Google Scholar] [CrossRef] [PubMed]
- Barello, S.; Acampora, M.; Grimaldi, L.; Maccacaro, C.; Dell’Acqua, S.; Spina, B.; Giangreco, D. “Health without Borders”: Early Findings and Lessons Learned from a Health Promotion Program for Ethnic Minorities Living in Italy. Int. J. Environ. Res. Public Health 2023, 20, 5646. [Google Scholar] [CrossRef]
- Fernandez-Rozadilla, C.; Timofeeva, M.; Chen, Z.; Law, P.; Thomas, M.; Schmit, S.; Diez-Obrero, V.; Hsu, L.; Fernandez-Tajes, J.; Palles, C.; et al. Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries. Nat. Genet. 2023, 55, 89–99. [Google Scholar] [CrossRef] [PubMed]
- Odunsi, K. Perspectives on Disparities and Equity in Cancer Outcomes: A Call to Action. Acad. Med. 2023, 98, S54–S59. [Google Scholar] [CrossRef]
- Acoba, J.D.; Yin, C.; Meno, M.; Abe, J.; Pagano, I.; Tamashiro, S.; Fujinaga, K.; Braun-Inglis, C.; Fukui, J. Racial Disparities in Patient-Provider Communication During Telehealth Visits Versus Face-to-face Visits among Asian and Native Hawaiian and Other Pacific Islander Patients with Cancer: Cross-sectional Analysis. JMIR Cancer 2022, 8, e37272. [Google Scholar] [CrossRef] [PubMed]
- Liu, Y.; Kornfield, R.; Yang, E.F.; Burnside, E.; Keevil, J.; Shah, D.V. Patient-provider communication while using a clinical decision support tool: Explaining satisfaction with shared decision making for mammography screening. BMC Med. Inform. Decis. Mak. 2022, 22, 323. [Google Scholar] [CrossRef]
- Symanski, E.; An Han, H.; McCurdy, S.; Hopkins, L.; Flores, J.; Han, I.; Smith, M.A.; Caldwell, J.; Fontenot, C.; Wyatt, B.; et al. Data to Action: Community-Based Participatory Research to Address Concerns about Metal Air Pollution in Overburdened Neighborhoods near Metal Recycling Facilities in Houston. Environ. Health Perspect. 2023, 131, 67006. [Google Scholar] [CrossRef]
- Milton, A.J.; Flores, E.J.; Charles, E.F.; Elezaby, M.A.; Ward, E.C.; Lee, C.I.; Woods, R.W.; Martin Rother, M.D.; Strigel, R.M.; Narayan, A.K. Community-based Participatory Research: A Practical Guide for Radiologists. Radiographics 2023, 43, e220145. [Google Scholar] [CrossRef] [PubMed]
- Morrell, M.A.; Willis, T.R.; Brown, D.R.; O’Brian, C.A.; Post, S.L.; Woloschak, G.E.; Bonini, M.G.; Paunesku, T.; Popovic, J.; Manning, T.M.; et al. Lessons learned in the practice of community-based participatory research with community partner collaboration in study design and implementation: The community scientist model. Cancer Causes Control 2023, 34, 621–624. [Google Scholar] [CrossRef] [PubMed]
- Anderson, M.D.; Pickner, W.J.; Begnaud, A. Determinants of Lung Cancer Screening in a Minnesota Urban Indigenous Community: A Community-Based, Participatory, Action-Oriented Study. Cancer Prev. Res. 2023, 16, 239–245. [Google Scholar] [CrossRef] [PubMed]
- Rivas, G.; Rodriguez-Colon, S.; Ramirez, S.I.; Galdamez, C.; Valdez, S.; Shirley, S.; Diaz-Myers, M.; Lengerich, E.J. Evaluation of the Spanish-Language Cancer Educational Webinar Series “Vamos a educarnos contra el cancer” with the RE-AIM Framework. J. Cancer Educ. 2023, 38, 1629–1635. [Google Scholar] [CrossRef] [PubMed]
- Warner, Z.C.; Gilbert-Gard, K.; Reid, B.; Joseph, W.; Kepka, D.; Auguste, P.; Warner, E.L. Knowledge and awareness of colorectal cancer among a predominantly Indigenous Caribbean community. BMC Public Health 2023, 23, 243. [Google Scholar] [CrossRef] [PubMed]
- Alpert, J.M.; Morris, B.B.; Thomson, M.D.; Matin, K.; Brown, R.F. Identifying How Patient Portals Impact Communication in Oncology. Health Commun. 2019, 34, 1395–1403. [Google Scholar] [CrossRef]
- Engle, R.L.; Bokhour, B.G.; Rose, A.J.; Reisman, J.I.; Jasuja, G.K. Characterizing patient attitudes and beliefs towards testosterone therapy in Veterans Affairs: A qualitative study. Patient Educ. Couns. 2023, 106, 201–207. [Google Scholar] [CrossRef]
- Stolwijk, M.L.; van Nispen, R.M.A.; van der Ham, A.J.; Veenman, E.; van Rens, G. Barriers and facilitators in the referral pathways to low vision services from the perspective of patients and professionals: A qualitative study. BMC Health Serv. Res. 2023, 23, 64. [Google Scholar] [CrossRef]
- Benham-Hutchins, M.; Staggers, N.; Mackert, M.; Johnson, A.H.; deBronkart, D. “I want to know everything”: A qualitative study of perspectives from patients with chronic diseases on sharing health information during hospitalization. BMC Health Serv. Res. 2017, 17, 529. [Google Scholar] [CrossRef]
- Hamilton, J.G.; Hutson, S.P.; Frohnmayer, A.E.; Han, P.K.; Peters, J.A.; Carr, A.G.; Alter, B.P. Genetic Information-Seeking Behaviors and Knowledge among Family Members and Patients with Inherited Bone Marrow Failure Syndromes. J. Genet. Couns. 2015, 24, 760–770. [Google Scholar] [CrossRef]
- Ratnapradipa, K.L.; Ranta, J.; Napit, K.; Luma, L.B.; Robinson, T.; Dinkel, D.; Schabloske, L.; Watanabe-Galloway, S. Qualitative analysis of cancer care experiences among rural cancer survivors and caregivers. J. Rural. Health 2022, 38, 876–885. [Google Scholar] [CrossRef] [PubMed]
- Sanderson, P.R.; Teufel-Shone, N.I.; Baldwin, J.A.; Sandoval, N.; Robinson, F. Breast cancer education for Navajo women: A pilot study evaluating a culturally relevant video. J. Cancer Educ. 2010, 25, 217–223. [Google Scholar] [CrossRef] [PubMed]
- Ye, Y. The role of illness factors and patient satisfaction in using online health support groups. Health Commun. 2014, 29, 355–363. [Google Scholar] [CrossRef]
- Bayram, T.; Sakarya, S. Oppression and internalized oppression as an emerging theme in accessing healthcare: Findings from a qualitative study assessing first-language related barriers among the Kurds in Turkey. Int. J. Equity Health 2023, 22, 6. [Google Scholar] [CrossRef]
- Hu, S.Y.; Reel, E.; Nisenbaum, R.; Scheer, A.S. Challenges in Cross-Cultural Communication in Breast Cancer Surgery: Is there a Gender Gap? J. Cancer Educ. 2022, 37, 1201–1208. [Google Scholar] [CrossRef] [PubMed]
- Rosa, W.E.; Roberts, K.E.; Braybrook, D.; Harding, R.; Godwin, K.; Mahoney, C.; Mathew, S.; Atkinson, T.M.; Banerjee, S.C.; Haviland, K.; et al. Palliative and end-of-life care needs, experiences, and preferences of LGBTQ+ individuals with serious illness: A systematic mixed-methods review. Palliat. Med. 2023, 37, 460–474. [Google Scholar] [CrossRef]
- Morena, N.; Zelt, N.; Nguyen, D.; Dionne, E.; Rentschler, C.A.; Greyson, D.; Meguerditchian, A.N. The Use of Web-Based Patient Reviews to Assess Medical Oncologists’ Competency: Mixed Methods Sequential Explanatory Study. JMIR Form. Res. 2023, 7, e39857. [Google Scholar] [CrossRef]
- Stewart, E.C.; Davis, J.S.; Walters, T.S.; Chen, Z.; Miller, S.T.; Duke, J.M.; Alexander, L.R.; Akohoue, S.A.; Russell, R.; Rowan, N.; et al. Development of strategies for community engaged research dissemination by basic scientists: A case study. Transl. Res. 2023, 252, 91–98. [Google Scholar] [CrossRef]
- Broadbridge, E.; Greene, K.; Venetis, M.K.; Lee, L.E.; Banerjee, S.C.; Saraiya, B.; Devine, K.A. Facilitating psychological adjustment for breast cancer patients through empathic communication and uncertainty reduction. Patient Educ. Couns. 2023, 114, 107791. [Google Scholar] [CrossRef]
- Korsvold, L.; Mellblom, A.V.; Lie, H.C.; Ruud, E.; Loge, J.H.; Finset, A. Patient-provider communication about the emotional cues and concerns of adolescent and young adult patients and their family members when receiving a diagnosis of cancer. Patient Educ. Couns. 2016, 99, 1576–1583. [Google Scholar] [CrossRef]
- Posma, E.R.; van Weert, J.C.; Jansen, J.; Bensing, J.M. Older cancer patients’ information and support needs surrounding treatment: An evaluation through the eyes of patients, relatives and professionals. BMC Nurs. 2009, 8, 1. [Google Scholar] [CrossRef] [PubMed]
- Lin, J.J.; Lake, J.; Wall, M.M.; Berman, A.R.; Salazar-Schicchi, J.; Powell, C.; Keller, S.M.; Halm, E.A.; Leventhal, H.; Wisnivesky, J.P. Association of patient-provider communication domains with lung cancer treatment. J. Thorac. Oncol. 2014, 9, 1249–1254. [Google Scholar] [CrossRef] [PubMed]
- Makoul, G. The interplay between education and research about patient-provider communication. Patient Educ. Couns. 2003, 50, 79–84. [Google Scholar] [CrossRef] [PubMed]
- Bogdan-Lovis, E.; Zhuang, J.; Goldbort, J.; Shareef, S.; Bresnahan, M.; Kelly-Blake, K.; Elam, K. Do Black birthing persons prefer a Black health care provider during birth? Race concordance in birth. Birth 2023, 50, 310–318. [Google Scholar] [CrossRef]
- Chou, W.Y.; Han, P.; Pilsner, A.; Coa, K.; Greenberg, L.; Blatt, B. Interdisciplinary research on patient-provider communication: A cross-method comparison. Commun. Med. 2011, 8, 29–40. [Google Scholar] [CrossRef]
- Seible, D.M.; Kundu, S.; Azuara, A.; Cherry, D.R.; Arias, S.; Nalawade, V.V.; Cruz, J.; Arreola, R.; Martinez, M.E.; Nodora, J.N.; et al. The Influence of Patient-Provider Language Concordance in Cancer Care: Results of the Hispanic Outcomes by Language Approach (HOLA) Randomized Trial. Int. J. Radiat. Oncol. Biol. Phys. 2021, 111, 856–864. [Google Scholar] [CrossRef]
- Shaw, A.C.; McQuade, J.L.; Reilley, M.J.; Nixon, B.; Baile, W.F.; Epner, D.E. Integrating Storytelling into a Communication Skills Teaching Program for Medical Oncology Fellows. J. Cancer Educ. 2019, 34, 1198–1203. [Google Scholar] [CrossRef]
- Ward, M.; Elder, B.; Habtemariam, M. Current Testing Guidelines: A Retrospective Analysis of a Community-Based Hereditary Cancer Program. J. Adv. Pract. Oncol. 2021, 12, 693–701. [Google Scholar] [CrossRef]
- Eliacin, J.; Burgess, D.; Rollins, A.L.; Patterson, S.; Damush, T.; Bair, M.J.; Salyers, M.P.; Spoont, M.; Chinman, M.; Slaven, J.E.; et al. Outcomes of a peer-led navigation program, PARTNER-MH, for racially minoritized Veterans receiving mental health services: A pilot randomized controlled trial to assess feasibility and acceptability. Transl. Behav. Med. 2023, 13, 710–721. [Google Scholar] [CrossRef]
- Gage-Bouchard, E.A. Social support, flexible resources, and health care navigation. Soc. Sci. Med. 2017, 190, 111–118. [Google Scholar] [CrossRef]
- Molina, Y.; Kim, S.J.; Berrios, N.; Glassgow, A.E.; San Miguel, Y.; Darnell, J.S.; Pauls, H.; Vijayasiri, G.; Warnecke, R.B.; Calhoun, E.A. Patient Navigation Improves Subsequent Breast Cancer Screening after a Noncancerous Result: Evidence from the Patient Navigation in Medically Underserved Areas Study. J. Womens Health 2018, 27, 317–323. [Google Scholar] [CrossRef]
- Molina, Y.; Glassgow, A.E.; Kim, S.J.; Berrios, N.M.; Pauls, H.; Watson, K.S.; Darnell, J.S.; Calhoun, E.A. Patient Navigation in Medically Underserved Areas study design: A trial with implications for efficacy, effect modification, and full continuum assessment. Contemp. Clin. Trials 2017, 53, 29–35. [Google Scholar] [CrossRef]
- Heisler, M.; Lapidos, A.; Henderson, J.; Guzman, R.M.; Wolfe, J.; Meyer, P.; Law, D.; Kieffer, E.C.; Ernst, C.; Djelaj, V.; et al. Study protocol for a Community Health Worker (CHW)-led comprehensive neighborhood-focused program for medicaid enrollees in detroit. Contemp. Clin. Trials Commun. 2019, 16, 100456. [Google Scholar] [CrossRef]
- Izumi, B.T.; Schulz, A.J.; Israel, B.A.; Reyes, A.G.; Martin, J.; Lichtenstein, R.L.; Wilson, C.; Sand, S.L. The one-pager: A practical policy advocacy tool for translating community-based participatory research into action. Prog. Community Health Partnersh. 2010, 4, 141–147. [Google Scholar] [CrossRef]
- Pulte, D.; Redaniel, M.T.; Brenner, H.; Jeffreys, M. Changes in survival by ethnicity of patients with cancer between 1992-1996 and 2002–2006: Is the discrepancy decreasing? Ann. Oncol. 2012, 23, 2428–2434. [Google Scholar] [CrossRef]
- Yang, H.T.; Wu, M.C.; Shun, S.C. Care Plan for Resuming the Physical Activity of Patients with Pancreatic Cancer and Diabetes after Surgery. Hu Li Za Zhi 2018, 65, 104–111. [Google Scholar] [CrossRef]
- Arthur, A.E.; Delk, A.; Demark-Wahnefried, W.; Christein, J.D.; Contreras, C.; Posey, J.A., 3rd; Vickers, S.; Oster, R.; Rogers, L.Q. Pancreatic cancer survivors’ preferences, barriers, and facilitators related to physical activity and diet interventions. J. Cancer Surviv. 2016, 10, 981–989. [Google Scholar] [CrossRef]
- Youn, P.; Li, H.; Milano, M.T.; Stovall, M.; Constine, L.S.; Travis, L.B. Long-term survival among Hodgkin’s lymphoma patients with gastrointestinal cancer: A population-based study. Ann Oncol 2013, 24, 202–208. [Google Scholar] [CrossRef]
- Huang, B.Z.; Wang, S.; Bogumil, D.; Wilkens, L.R.; Wu, L.; Blot, W.J.; Zheng, W.; Shu, X.O.; Pandol, S.J.; Le Marchand, L.; et al. Red meat consumption, cooking mutagens, NAT1/2 genotypes and pancreatic cancer risk in two ethnically diverse prospective cohorts. Int. J. Cancer 2021, 149, 811–819. [Google Scholar] [CrossRef]
- Zoellner, J.M.; Porter, K.J.; Brock, D.P.; Mitchell, E.M.K.; Chapman, H., Jr.; Clarkston, D.; Cohn, W.; Hauser, L.; Morris, D.W.; Ramey, S.Y.; et al. Advancing engagement and capacity for rural cancer control: A mixed-methods case study of a Community-Academic Advisory Board in the Appalachia region of Southwest Virginia. Res. Involv. Engagem. 2021, 7, 44. [Google Scholar] [CrossRef]
- Batai, K.; Sanderson, P.R.; Joshweseoma, L.; Burhansstipanov, L.; Russell, D.; Joshweseoma, L.; Hsu, C.H. Formative Assessment to Improve Cancer Screenings in American Indian Men: Native Patient Navigator and mHealth Texting. Int. J. Environ. Res. Public Health 2022, 19, 6546. [Google Scholar] [CrossRef]
- Dockery, L.E.; Motwani, A.; Ding, K.; Doescher, M.; Dvorak, J.D.; Moore, K.N.; Holman, L.L. Improving cancer care for American Indians with cervical cancer in the Indian Health Service (IHS) system-Navigation may not be enough. Gynecol. Oncol. 2018, 149, 89–92. [Google Scholar] [CrossRef]
- Bernardes, C.M.; Martin, J.; Cole, P.; Kitchener, T.; Cowburn, G.; Garvey, G.; Walpole, E.; Valery, P.C. Lessons learned from a pilot study of an Indigenous patient navigator intervention in Queensland, Australia. Eur. J. Cancer Care 2018, 27, e12714. [Google Scholar] [CrossRef]
- Burhansstipanov, L.; Krebs, L.U.; Dignan, M.B.; Jones, K.; Harjo, L.D.; Watanabe-Galloway, S.; Petereit, D.G.; Pingatore, N.L.; Isham, D. Findings from the native navigators and the Cancer Continuum (NNACC) study. J. Cancer Educ. 2014, 29, 420–427. [Google Scholar] [CrossRef]
- Arredondo, E.M.; Haughton, J.; Ayala, G.X.; Slymen, D.; Sallis, J.F.; Perez, L.G.; Serrano, N.; Ryan, S.; Valdivia, R.; Lopez, N.V.; et al. Two-year outcomes of Faith in Action/Fe en Accion: A randomized controlled trial of physical activity promotion in Latinas. Int. J. Behav. Nutr. Phys. Act. 2022, 19, 97. [Google Scholar] [CrossRef]
- Lee, S.; Niakosari Hadidi, N.; Lindgren, B.R.; Kelley, R.; Lindquist, R. Peer Group Support Intervention to Reduce Cardiovascular Disease Risk for African American Men According to Life’s Simple 7 in Faith-Based Communities. Res. Theory Nurs. Pract. 2022, 36, 280–300. [Google Scholar] [CrossRef]
- Knott, C.L.; Miech, E.J.; Slade, J.; Woodard, N.; Robinson-Shaneman, B.J.; Huq, M. Evaluation of organizational capacity in the implementation of a church-based cancer education program. Glob. Implement. Res. Appl. 2022, 2, 22–33. [Google Scholar] [CrossRef]
- Maxwell, A.E.; Lucas-Wright, A.; Gatson, J.; Cindy Chang, L.; Crespi, C.M. Training Community Health Advisors in African American Churches: Do Training Outcomes Predict Performance? J. Cancer Educ. 2020, 35, 395–402. [Google Scholar] [CrossRef]
- Hamdiui, N.; Bouman, M.P.A.; Stein, M.L.; Crutzen, R.; Keskin, D.; Afrian, A.; van Steenbergen, J.E.; van den Muijsenbergh, M.; Timen, A. The development of a culturally sensitive educational video: How to facilitate informed decisions on cervical cancer screening among Turkish- and Moroccan-Dutch women. Health Expect 2022, 25, 2377–2385. [Google Scholar] [CrossRef]
- Del Valle, D.D.; Pardo, J.A.; Maselli, A.M.; Valero, M.G.; Fan, B.; Seyidova, N.; James, T.A.; Lee, B.T. Evaluation of online Spanish and English health materials for preventive mastectomy. are we providing adequate information? Breast Cancer Res. Treat. 2021, 187, 1–9. [Google Scholar] [CrossRef]
- Saif, M.W. From Screening to Treatment of Pancreatic Cancer: A Comprehensive Review. JOP 2021, 22, 70–79. [Google Scholar] [PubMed]
- Dionne-Odom, J.N.; Ejem, D.; Azuero, A.; Taylor, R.A.; Rocque, G.B.; Turkman, Y.; Thompson, M.A.; Knight, S.J.; Martin, M.Y.; Bakitas, M.A. Factors Associated with Family Caregivers’ Confidence in Future Surrogate Decision Making for Persons with Cancer. J. Palliat. Med. 2018, 21, 1705–1712. [Google Scholar] [CrossRef] [PubMed]
- Tang, C.C.; Draucker, C.; Tejani, M.A.; Von Ah, D. Patterns of interactions among patients with advanced pancreatic cancer, their caregivers, and healthcare providers during symptom discussions. Support Care Cancer 2018, 26, 3497–3506. [Google Scholar] [CrossRef] [PubMed]
- Sharp, L.; Mentor, K.; Deane, J.; Watson, E.; Roberts, K.J.; Silva, M.; Phillips, M.; Siriwardena, A.K.; Hammond, J.; Bradshaw, A.; et al. Assessing impact, needs and quality-of-life among informal carers of people with pancreatic cancer, a prospective study: The PAN-CARER study protocol. BMJ Open 2023, 13, e068178. [Google Scholar] [CrossRef]
- Abma, I.L.; Roelofs, L.C.G.; van der Kolk, M.B.; Mulder, S.F.; Schers, H.J.; Hermens, R.; van der Wees, P.J. Roles of general practitioners in shared decision-making for patients with cancer: A qualitative study. Eur. J. Cancer Care 2022, 31, e13594. [Google Scholar] [CrossRef]
- Griffioen, I.P.M.; Rietjens, J.A.C.; Melles, M.; Snelders, D.; Homs, M.Y.V.; van Eijck, C.H.; Stiggelbout, A.M. The bigger picture of shared decision making: A service design perspective using the care path of locally advanced pancreatic cancer as a case. Cancer Med. 2021, 10, 5907–5916. [Google Scholar] [CrossRef]
- Reissig, T.M.; Tzianopoulos, I.; Liffers, S.T.; Rosery, V.K.; Guyot, M.; Ting, S.; Wiesweg, M.; Kasper, S.; Meister, P.; Herold, T.; et al. Smaller panel, similar results: Genomic profiling and molecularly informed therapy in pancreatic cancer. ESMO Open 2023, 8, 101539. [Google Scholar] [CrossRef]
- Kim, C.A.; Lelond, S.; Daeninck, P.J.; Rabbani, R.; Lix, L.; McClement, S.; Chochinov, H.M.; Goldenberg, B.A. The impact of early palliative care on the quality of life of patients with advanced pancreatic cancer: The IMPERATIVE case-crossover study. Support Care Cancer 2023, 31, 250. [Google Scholar] [CrossRef]
- Jardim, S.R.; de Souza, L.M.P.; de Souza, H.S.P. The Rise of Gastrointestinal Cancers as a Global Phenomenon: Unhealthy Behavior or Progress? Int. J. Environ. Res. Public Health 2023, 20, 3640. [Google Scholar] [CrossRef]
- El Kaoutari, A.; Fraunhoffer, N.A.; Audebert, S.; Camoin, L.; Berthois, Y.; Gayet, O.; Roques, J.; Bigonnet, M.; Bongrain, C.; Ciccolini, J.; et al. Pancreatic ductal adenocarcinoma ubiquitination profiling reveals specific prognostic and theranostic markers. EBioMedicine 2023, 92, 104634. [Google Scholar] [CrossRef]
- Dhani, H.; Hinestrosa, J.P.; Izaguirre-Carbonell, J.; Balcer, H.I.; Kurzrock, R.; Billings, P.R. Case Report: Early detection of pancreatic pre-cancer lesion in multimodal approach with exosome liquid biopsy. Front. Oncol. 2023, 13, 1170513. [Google Scholar] [CrossRef] [PubMed]
- Zhao, Y.; Tang, J.; Jiang, K.; Liu, S.Y.; Aicher, A.; Heeschen, C. Liquid biopsy in pancreatic cancer-Current perspective and future outlook. Biochim. Biophys. Acta Rev. Cancer 2023, 1878, 188868. [Google Scholar] [CrossRef] [PubMed]
- Roth, G.S.; Fayet, Y.; Benmameche-Medjahed, S.; Ducimetiere, F.; Charreton, A.; Cropet, C.; Chabaud, S.; Marion-Audibert, A.M.; Berthelet, O.; Walter, T.; et al. Structural and Socio-Spatial Determinants Influencing Care and Survival of Patients with a Pancreatic Adenocarcinoma: Results of the PANDAURA Cohort. Cancers 2022, 14, 5413. [Google Scholar] [CrossRef]
- Wang, F.; Shu, X.; Pal, T.; Berlin, J.; Nguyen, S.M.; Zheng, W.; Bailey, C.E.; Shu, X.O. Racial/Ethnic Disparities in Mortality Related to Access to Care for Major Cancers in the United States. Cancers 2022, 14, 3390. [Google Scholar] [CrossRef] [PubMed]
- Raoof, S.; Lee, R.J.; Jajoo, K.; Mancias, J.D.; Rebbeck, T.R.; Skates, S.J. Multicancer Early Detection Technologies: A Review Informed by Past Cancer Screening Studies. Cancer Epidemiol. Biomark. Prev. 2022, 31, 1139–1145. [Google Scholar] [CrossRef] [PubMed]
- Bledsoe, M.J.; Grizzle, W.E. Use of human specimens in research: The evolving United States regulatory, policy, and scientific landscape. Diagn. Histopathol. 2013, 19, 322–330. [Google Scholar] [CrossRef]
- Howell, L.A.; Sinicrope, P.S.; Brockman, T.A.; Patten, C.A.; Decker, P.A.; Ehlers, S.L.; Nadeau, A.; Rabe, K.G.; Breitkopf, C.R.; Petersen, G.M. Receptivity and preferences of pancreatic cancer family members for participating in lifestyle programs to reduce cancer risk. Hered. Cancer Clin. Pract. 2013, 11, 3. [Google Scholar] [CrossRef]
- Lavinia Loeffler, C.M.; El Nahhas, O.S.M.; Muti, H.S.; Seibel, T.; Cifci, D.; van Treeck, M.; Gustav, M.; Carrero, Z.I.; Gaisa, N.T.; Lehmann, K.V.; et al. Direct prediction of Homologous Recombination Deficiency from routine histology in ten different tumor types with attention-based Multiple Instance Learning: A development and validation study. medRxiv 2023. [Google Scholar] [CrossRef]
- Guest, D.D.; Cox, T.; Voss, A.C.; Kelley, K.; Ma, X.; Nguyen, A.; McMillen, K.; Williams, V.; Lee, J.A.; Petersen, J.; et al. Assessing Impact of Nutrition Care by Registered Dietitian Nutritionists on Patient Medical and Treatment Outcomes in Outpatient Cancer Clinics: A Cohort Feasibility Study. Nutr. Cancer 2023, 75, 923–936. [Google Scholar] [CrossRef]
- Pedrosa, L.; Araujo, I.K.; Cuatrecasas, M.; Soy, G.; Lopez, S.; Maurel, J.; Sanchez-Montes, C.; Montironi, C.; Sauri, T.; Sendino, O.; et al. Targeted transcriptomic analysis of pancreatic adenocarcinoma in EUS-FNA samples by NanoString technology. Front. Mol. Biosci. 2023, 10, 1161893. [Google Scholar] [CrossRef]
- Tsai, Y.S.; Chareddy, Y.S.; Price, B.A.; Parker, J.S.; Pecot, C.V. An integrated model for predicting KRAS dependency. PLoS Comput. Biol. 2023, 19, e1011095. [Google Scholar] [CrossRef] [PubMed]
- Yang, H.; Li, W.; Ren, L.; Yang, Y.; Zhang, Y.; Ge, B.; Li, S.; Zheng, X.; Liu, J.; Zhang, S.; et al. Progress on diagnostic and prognostic markers of pancreatic cancer. Oncol. Res. 2023, 31, 83–99. [Google Scholar] [CrossRef] [PubMed]
- Yu, Z.; Yang, Y.; Fang, W.; Hu, P.; Liu, Y.; Shi, J. Dual Tumor Exosome Biomarker Co-recognitions Based Nanoliquid Biopsy for the Accurate Early Diagnosis of Pancreatic Cancer. ACS Nano. 2023, 17, 11384–11395. [Google Scholar] [CrossRef] [PubMed]
- Heiselman, J.S.; Ecker, B.L.; Langdon-Embry, L.; O’Reilly, E.M.; Miga, M.I.; Jarnagin, W.R.; Do, R.K.G.; Horvat, N.; Wei, A.C.; Chakraborty, J. Registration-based biomarkers for neoadjuvant treatment response of pancreatic cancer via longitudinal image registration. J. Med. Imaging 2023, 10, 036002. [Google Scholar] [CrossRef]
- Vannini, I.; Rossi, T.; Melloni, M.; Valgiusti, M.; Urbini, M.; Passardi, A.; Bartolini, G.; Gallio, C.; Azzali, I.; Bandini, S.; et al. Analysis of EVs from patients with advanced pancreatic cancer identifies antigens and miRNAs with predictive value. Mol. Ther. Methods Clin. Dev. 2023, 29, 473–482. [Google Scholar] [CrossRef]
- Kane, L.E.; Mellotte, G.S.; Conlon, K.C.; Ryan, B.M.; Maher, S.G. Multi-Omic Biomarkers as Potential Tools for the Characterisation of Pancreatic Cystic Lesions and Cancer: Innovative Patient Data Integration. Cancers 2021, 13, 769. [Google Scholar] [CrossRef]
- Turanli, B.; Yildirim, E.; Gulfidan, G.; Arga, K.Y.; Sinha, R. Current State of “Omics” Biomarkers in Pancreatic Cancer. J. Pers. Med. 2021, 11, 127. [Google Scholar] [CrossRef]
- Xu, D.; Wang, Y.; Liu, X.; Zhou, K.; Wu, J.; Chen, J.; Chen, C.; Chen, L.; Zheng, J. Development and clinical validation of a novel 9-gene prognostic model based on multi-omics in pancreatic adenocarcinoma. Pharmacol. Res. 2021, 164, 105370. [Google Scholar] [CrossRef]
- De Pastena, M.; Esposito, A.; Paiella, S.; Surci, N.; Montagnini, G.; Marchegiani, G.; Malleo, G.; Secchettin, E.; Casetti, L.; Ricci, C.; et al. Cost-effectiveness and quality of life analysis of laparoscopic and robotic distal pancreatectomy: A propensity score-matched study. Surg. Endosc. 2021, 35, 1420–1428. [Google Scholar] [CrossRef]
- Chen, Q.; Merath, K.; Bagante, F.; Akgul, O.; Dillhoff, M.; Cloyd, J.; Pawlik, T.M. A Comparison of Open and Minimally Invasive Surgery for Hepatic and Pancreatic Resections among the Medicare Population. J. Gastrointest. Surg. 2018, 22, 2088–2096. [Google Scholar] [CrossRef]
- Reddy, A.; Amarnani, A.; Chen, M.; Dynes, S.; Flores, B.; Moshchinsky, A.; Lee, Y.J.; Kurbatov, V.; Shapira, I.; Vignesh, S.; et al. Privacy Concerns about Personal Health Information and Fear of Unintended Use of Biospecimens Impact Donations by African American Patients. J. Cancer Educ. 2020, 35, 522–529. [Google Scholar] [CrossRef]
- Peota, C. A question of consent. Minn. Med. 2012, 95, 7. [Google Scholar]
- Portman, D.G.; Thirlwell, S.; Donovan, K.A.; Ellington, L. Virtual Teaming: Leveraging Team Science Sense-Making During COVID-19. J. Patient Exp. 2021, 8, 1–7. [Google Scholar] [CrossRef]
- Katz, M.H.; Slack, R.; Bruno, M.; McMillan, J.; Fleming, J.B.; Lee, J.E.; Bednarski, B.; Papadopoulos, J.; Matin, S.F. Outpatient virtual clinical encounters after complex surgery for cancer: A prospective pilot study of “TeleDischarge”. J. Surg. Res. 2016, 202, 196–203. [Google Scholar] [CrossRef] [PubMed]
- Satturwar, S.; Monaco, S.E.; Xing, J.; Pantanowitz, L. The utility of cell blocks for international cytopathology teleconsultation by whole slide imaging. Cytopathology 2020, 31, 419–425. [Google Scholar] [CrossRef]
- Gustavell, T.; Sundberg, K.; Langius-Eklof, A. Using an Interactive App for Symptom Reporting and Management Following Pancreatic Cancer Surgery to Facilitate Person-Centered Care: Descriptive Study. JMIR Mhealth Uhealth 2020, 8, e17855. [Google Scholar] [CrossRef] [PubMed]
- Gustavell, T.; Sundberg, K.; Segersvard, R.; Wengstrom, Y.; Langius-Eklof, A. Decreased symptom burden following surgery due to support from an interactive app for symptom management for patients with pancreatic and periampullary cancer. Acta Oncol. 2019, 58, 1307–1314. [Google Scholar] [CrossRef] [PubMed]
- Jiang, J.; Chao, W.L.; Culp, S.; Krishna, S.G. Artificial Intelligence in the Diagnosis and Treatment of Pancreatic Cystic Lesions and Adenocarcinoma. Cancers 2023, 15, 2410. [Google Scholar] [CrossRef] [PubMed]
- Tovar, D.R.; Rosenthal, M.H.; Maitra, A.; Koay, E.J. Potential of artificial intelligence in the risk stratification for and early detection of pancreatic cancer. Artif. Intell. Surg. 2023, 3, 14–26. [Google Scholar] [CrossRef]
- Gagliardi, A.R.; Soong, D.; Gallinger, S. Identifying Factors Influencing Pancreatic Cancer Management to Inform Quality Improvement Efforts and Future Research: A Scoping Systematic Review. Pancreas 2016, 45, 161–166. [Google Scholar] [CrossRef]
- Low, C.A.; Li, M.; Vega, J.; Durica, K.C.; Ferreira, D.; Tam, V.; Hogg, M.; Zeh Iii, H.; Doryab, A.; Dey, A.K. Digital Biomarkers of Symptom Burden Self-Reported by Perioperative Patients Undergoing Pancreatic Surgery: Prospective Longitudinal Study. JMIR Cancer 2021, 7, e27975. [Google Scholar] [CrossRef] [PubMed]
- Cos, H.; Li, D.; Williams, G.; Chininis, J.; Dai, R.; Zhang, J.; Srivastava, R.; Raper, L.; Sanford, D.; Hawkins, W.; et al. Predicting Outcomes in Patients Undergoing Pancreatectomy Using Wearable Technology and Machine Learning: Prospective Cohort Study. J. Med. Internet Res. 2021, 23, e23595. [Google Scholar] [CrossRef] [PubMed]
- Nipp, R.D.; Gaufberg, E.; Vyas, C.; Azoba, C.; Qian, C.L.; Jaggers, J.; Weekes, C.D.; Allen, J.N.; Roeland, E.J.; Parikh, A.R.; et al. Supportive Oncology Care at Home Intervention for Patients with Pancreatic Cancer. JCO Oncol. Pract. 2022, 18, e1587–e1593. [Google Scholar] [CrossRef] [PubMed]
Research Group | Action | Mission | Year | Citation |
---|---|---|---|---|
AACR | CBPR/CSI/PAE | To provide culturally tailored education, screening events, and support for early detection of PCa in African American Communities | 1907 | https://www.aacr.org/, accessed on 19 September 2023 |
Pancreatic Cancer Action Network (PanCAN) | CBPR/PAE | Advocacy to improve the lives of individuals with PCa while also raising awareness and funding for PCa. | 1999 | https://pancan.org/, accessed on 19 September 2023 |
the Patient Navigation in Medically Underserved Areas (PNMUA) | CSI/PAE | To provide improved access to treatment and promote early detection of cancer underserved populations, especially those with limited access to healthcare. | 2005 | [187,188] |
Asian Liver Center at Stanford University | CBPR/CSI | To provide bilingual outreach and culturally appropriate education materials to the Asian community, to reduce the disparity of liver cancer. | 1996 | https://med.Stanford.edu/liver.html, accessed on 19 September 2023 |
High-Risk Pancreatic Cancer Clinic in theSkip Viragh Center for Pancreatic Cancer | CBPR/PAE | To initiate screenings on individuals with family history of PCa or known genetic mutations associated with PCa. | 2003 | https://www.hopkinsmedicine.org/kimmel-cancer-center/cancers-we-treat/pancreatic-cancer, accessed on 19 September 2023 |
The Detroit Urban Research Center (DURC) | CBPR | To conduct impactful research in the health disparities around Detroit and implement studies, community outreach programs, and policy advocacy efforts. | 1995 | [189,190] |
The Appalachian Community Cancer Network (ACCN) | CBPR | To engage community members, healthcare providers, and researchers and identify community needs, develop interventions, and evaluate their effectiveness | 2021 | [194] |
Latino Community Research (Various) | CBPR | To collaborate researchers, community organizations, health clinics, and individuals from Latino backgrounds to identify cultural beliefs, barriers to care, and information needs related to Pea. | NA | [191,192,193] |
Project ECHO (Extension for Community Healthcare Outcomes) | CSI | To improve PCa care in underserved communities by connecting specialists with primary care providers and community health workers to deliver training, mentorship, and support in a culturally sensitive worldview. | 2023 | https://www.aap.org/en/practice-management/project-echo/, accessed on 19 September 2023 |
Faith Based Organizations (Various) | CSI | To promote partnerships with healthcare workers to facilitate community outreach, education, and support programs while also addressing the spiritual needs of the patrons. | NA | [202,203,204,205] |
Community Health Workers (Various) | CSI/PAE | To mentor peers, patients and other community members to bridge the gap with cultural barriers and tailor innovations to meet specific cultural needs. | NA | [206,207,208] |
Patient Support Groups/Online Communities and Forums | PAE | To inspire and empower patients by brining unique experiences and companionship to those currently suffering with the psychological and physical implications of cancer. | NA | [69,138] |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Wall, N.R.; Fuller, R.N.; Morcos, A.; De Leon, M. Pancreatic Cancer Health Disparity: Pharmacologic Anthropology. Cancers 2023, 15, 5070. https://doi.org/10.3390/cancers15205070
Wall NR, Fuller RN, Morcos A, De Leon M. Pancreatic Cancer Health Disparity: Pharmacologic Anthropology. Cancers. 2023; 15(20):5070. https://doi.org/10.3390/cancers15205070
Chicago/Turabian StyleWall, Nathan R., Ryan N. Fuller, Ann Morcos, and Marino De Leon. 2023. "Pancreatic Cancer Health Disparity: Pharmacologic Anthropology" Cancers 15, no. 20: 5070. https://doi.org/10.3390/cancers15205070